, , 2017.
Guidelines for the management of valvular heart disease, Eur Heart J, vol.4, pp.2739-91, 2017. ,
AHA/ACC Focused Update of the 6, 2017. ,
Guideline for the Management of Patients With Valvular Heart Disease: A 7 Report of the American College of Cardiology, American Heart Association Task Force on, vol.8 ,
, Clinical Practice Guidelines. Circulation, vol.135, pp.1159-95, 2017.
Updated standardized endpoint definitions 10 for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 11 consensus document, J Am Coll Cardiol, vol.60, pp.1438-54, 2012. ,
Transfemoral aortic valve replacement with the 13 ,
prosthesis using exclusively local anesthesia and 14 fluoroscopic guidance: feasibility and thirty-day outcomes, JACC Cardiovasc Interv, vol.15, pp.461-468, 2012. ,
Feasibility and safety of early discharge 17 after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT 18 prosthesis, Am J Cardiol, vol.115, pp.1116-1138, 2015. ,
, Prospective Analysis of Early, vol.20
, Discharge After Transfemoral Transcatheter Aortic Valve Implantation, Am J Cardiol, vol.21, pp.866-72, 2016.
Early discharge after transfemoral 23 transcatheter aortic valve implantation, Heart, vol.101, pp.1485-90, 2015. ,